| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 799.66 | 13.9% | 113.7% |
| Total Income | 851.28 | 13.2% | 112.4% |
| Expenditure | 212.04 | 7.4% | 39.6% |
| PBT | 639.24 | 22.2% | 156.8% |
| Net Profit | 454.57 | 9.9% | 130.2% |
| OPM | 76.35% | 5.98pp | 11.65pp |
| NPM | 53.40% | 1.58pp | 4.13pp |
| EPS | 17.83 | 10.0% | 54.0% |
Record margins, strong growth; execution on new products key
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Hit prior guidance expectation ('manageable' RBI impact). SGF reduction, tech scaling delivered. Absorbed regulatory headwinds seamlessly.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Exceptional Q2 delivery (113.7% revenue, 130.2% PAT growth) with world-class 53% NPM. Structural tailwinds (FPI entry, commodity hedging adoption, new products) support long-term growth. Near-term risk: margins at cycle peak (volatility-dependent), competition acknowledged, new product execution unproven.
₹799.7 Cr
Revenue · +113.7% YoY₹454.6 Cr
Reported PAT · +130.2% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
H1 revenue ₹1,501 Cr with 101% YoY growth
METQ2 alone ₹799.7 Cr, 113.7% YoY; implies Q1 ₹701 Cr with ~95% growth
H1 PAT ₹868 Cr with 117% YoY growth
METQ2 alone ₹454.6 Cr, 130.2% YoY; Q1 ~₹413 Cr, ~104% growth
Average daily turnover ₹12.6 lakh crores, 20% QoQ growth from ₹10 lakh
METOperational metric confirmed in call; 20% QoQ = strong momentum
EBITDA margin 75%, scalable business model
OVERSTATEDQ2 NPM 53.4%, OPM 76.3%; margins exceptional but management cautious on sustainability
Silver 100-gram futures ₹100+ Cr ADT running
UnverifiedNew product launched this year; volume claim unverified from disclosed results
Earnings quality
What changed since the last call
RBI bank guarantee impact absorbed
NeutralPrior guidance flagged July regulatory change as 'deferred to Q2, expected manageable.' Q2 delivered with no material margin proportionality shift. Managed successfully.
SGF contribution reduced
UpgradeSEBI August 2026 circular cut requirement 10% → 5%, boosting profitability. One-time tailwind; not sustainable at current margins.
Leadership strengthened
UpgradeSanjay Rajpal (Ex-Amazon) joins as ED Operations; Manoj Jain promoted to ED Regulatory. Org depth improved for scale.
Technology capacity doubled
UpgradeInfrastructure scaling completed; platform now handles 2x peaks seamlessly. De-risks growth capacity through FY27-28.
The Q&A
Analysts pressed hard on FPI execution timeline, EBITDA sustainability, and competition. Management answered but with caveats: FPI adoption gradual (250 onboarded, 'single-digit' volumes), margins volatile (tied to cost investments), competition respected but 25y+ incumbent advantage held.
FPI participation & scale — Sameet Sinha, Macquarie
Partial~250 FPIs onboarded. Permitted on cash-settled energy currently. Expect over-time increasing role as circulars finalize. Baseline conservative; execution gradual.
H2 trajectory post strong H1 — Sameet Sinha, Macquarie
DodgedPlatform serves macro volatility; baseline improves each step. No specific numbers given. EBITDA depends on growth pace, costs, market volatility.
Product license fee & tech cost drivers — Madhukar Ladha, JP Morgan
AnsweredFees proportional to crude-price CME-derived rate (volume-linked). Tech cost from doubled capacity maintenance. No further cost growth expected.
Retail participation trend — Amit Chandra, HDFC Securities
PartialRetail growth across board; no single segment dominant. Safe investing awareness campaigns launched. Brick-by-brick participation building.
Bank guarantee rule impact on volumes — Devesh Agarwal, IIFL Capital
AnsweredProportionality unchanged; controls established; no hidden impact. Prop-to-retail mix saw participation grow across segments. Watched closely.
SGF cost and future requirement — Sanketh Godha, Avendus Spark
PartialCurrent Q2 does NOT include SGF portion; other contributions included. Future SGF tied to open interest; complex formula. Will re-evaluate each quarter.
EBITDA margin sustainability — Smita Mohta, Samriddhi Finvest
PartialProfitability planned each quarter. Great Q3 some years, great Q1 others. Won't focus on single quarter. Investments ongoing, margins will fluctuate; overall improving baseline.
Market share risk vs competition — Aditya Yadav, Transient Capital
DefensiveMCX welcomes market expansion. Not much headway lost till now. Competition building; we take it seriously, stay competitive, expand participation.
Risk management & cybersecurity — Ankush Modi, Individual Investor
AnsweredTop 2 risks: volatility (creates opportunity and risk) and cyber. CISO and ED closely monitor. Incidents reviewed immediately vs internal systems. Proactive posture elevated.
Electricity derivatives expansion — Ganesh Radhakrishnan, Individual Investor
AnsweredQ2 ADT ₹77 Cr, 75% market share. Depth good; 1,500-1,600 lots. VCP adoption growing. Can be big market ahead.
Guidance
No numeric FY27 revenue target given
LowPrior call: 'growth momentum expected at fundamental level.' Q2 delivery 113.7% YoY validates momentum. No forward number provided; volume/volatility dependent.
EBITDA margins will fluctuate with growth, costs, market volatility
MediumQ2 EBITDA margin 75% flagged as cycle peak. Management: 'profitability planned each quarter' not quarterly focus. Will invest, margins volatile.
Effective tax rate expected closer to 25% going forward
MediumQ2 tax rate elevated due to Q1 provision adjustment on SEBI SGF revaluation. Normalized rate 25% expected baseline.
Technology scaling capex largely complete; maintenance/incremental expected
MediumCapacity doubled; 'associated operating expenses' ongoing (maintenance, scaling activities). No major new capex cycle expected near-term.
Risks the call surfaced
Margin compression
HighQ2 NPM 53.4% at cycle peak. Base volatility-dependent; volume growth from 2x YoY will decelerate; SGF benefit one-time; new investments will offset margins.
FPI execution risk
Medium~250 FPIs onboarded on permitted cash-settled energy contracts. Non-agri commodity circular (gold, silver) still pending formalization. Participation in 'late single-digit numbers' — slow initial traction.
Competitive market share loss
MediumCompetitor showed 'massive ADT jump' in derivatives H1. MCX at ~90% market share; management acknowledges 'competition building' and 'not much headway lost till now' but proactive monitoring needed.
Regulatory uncertainty
MediumFPI circular for non-agri pending. SGF requirement could rise again if open interest thresholds breached (complex formula). Tax treatment of subsidiary MCXCCL revaluation created Q2 provision; future impact unclear.
Cybersecurity
MediumRecent cyber attacks globally; AI and simple vulnerabilities exploited. MCX critical infrastructure; breach = trust loss, regulatory action, operational disruption. Management flagged as 'top 2 risk.'
New product adoption risk
LowSilver 100g futures ₹100+ Cr ADT, silver micro-options early traction, electricity 75% share but execution-dependent, agriculture low base. Market maturation pace unpredictable.
Management
Score 7/10. Clear on operational metrics and market trends. Transparent on regulatory headwinds and cybersecurity risks. Evasive on EBITDA sustainability and specific margin targets; uses 'baseline improvement' language instead of numeric guidance. Delivered 113.7% revenue, 130.2% PAT growth vs prior 'manageable' regulatory impact expectation. Technology scaling, new products, leadership bench-building all executed. Track record solid; no missed guidance (none given prior).
1 · H2 FY27
FPI regulatory clarity for non-agri commodities; circular pending formalization
2 · Q3 FY27
Silver micro-options, extended-tenure contracts stabilize; electricity derivatives scale
3 · ongoing
Technology platform handles 2x capacity; new ED from Amazon signals ops scaling
Near-term risk: margins at cycle peak (volatility-dependent), competition acknowledged, new product execution unproven.
Operating leverage intact: can MCX sustain Q1's 88% revenue growth?
Q1 FY27 shattered Street expectations with 103% profit growth on a derivative-trading surge. Analysts now watch whether bullion and energy volumes hold, and if the ₹540+ Cr GST show-cause notice signals margin risk.
What to expect in Q2 FY27
MCX delivered a shock print in Q1 FY27: consolidated profit surged 103% to ₹413 Cr and revenue jumped 88% to ₹702 Cr, powered by a 151% surge in transaction fees from commodity derivatives. The Street had modeled ₹478–538 Cr profit; MCX cleared that with margin discipline, posting a 55% net profit margin and a 72% EBITDA margin. The test now: is this sustainable, or was Q1 a volatility-driven spike?
~₹580–620 Cr
40–50% YoY growth baseline; watch for sequential volatility in bullion/energy turnover
~65–70%
Q1 posted 72%; assume modest seasonal compression; GST impact TBD by resolution
~₹325–375 Cr
Street consensus ₹350+ Cr; 75–90% YoY growth would validate momentum
Track growth
Aug contracts rose 4.3×; Sep/Oct figures critical to assess structural shift
A strong Q2 print would show revenue holding above ₹580 Cr, EBITDA margin above 65%, and profit approaching ₹350 Cr—confirming that the Q1 surge was not a one-quarter event but a reflection of elevated commodity hedging demand and sustained broker participation growth. A weak print would see revenue below ₹550 Cr, margins compressing below 60%, or profit falling short of ₹300 Cr, signaling either seasonal volatility or a loss of momentum in derivatives participation.
On track for FY27 guidance?
MCX has not issued formal full-year guidance, but the Street consensus for FY27 earnings per share stands at ₹191 (vs ₹158 in FY26), implying a consolidated profit run-rate of ~₹1,800–1,900 Cr for the full year. Q1's ₹413 Cr represents 22–23% of that target; Q2 is typically strong for commodity exchanges (summer energy and monsoon agricultural hedging), so a ₹350+ Cr quarter would put FY27 on track. If Q2 disappoints—say, ₹300 Cr or below—the Street will recalibrate FY27 guidance downward and reassess the sustainability of the 100%+ earnings CAGR that analysts have priced in.
What the Street says
Since last quarter: filings & risk watch
1 · GST show-cause notice (Sep 30): ₹540.84 Cr tax demand + ₹43.82 Cr interest
MCX received a GST Department show-cause notice proposing a ₹54.08 Cr tax demand plus ₹43.82 Cr interest on disputed service tax classification. This is a material contingent liability for Q2 disclosures. Resolution timeline unclear; if upheld, could trigger a one-time charge to Q2–Q3 earnings. Margin watch: any provision taken in Q2 would compress profit.
2 · New subsidiary: MCX Mineral Exchange (Oct 16)
MCX incorporated a wholly-owned subsidiary, MCX Mineral Exchange of India Limited, following SEBI approval in Aug. This signals management's bet on mineralspot trading as a growth vector (currently not a core revenue driver). Monitor for consolidation timing and initial contributions.
3 · Management transitions (Oct 9): 3 KMPs shifted roles
Rashmi Nihalani (Head–Research to Head–Strategy), Chittaranjan Rege (Head–Metals to Head–Strategic Corporates), Shivanshu Mehta (interim CBO to Chief of Product). Routine reshuffle; no material impact on operations, though new Chief of Product role suggests product innovation focus aligns with Street's bullish thesis on options/monthly contracts.
4 · Further investments in bullion subsidiary (Aug–Sep)
MCX invested ₹10 Cr (Aug) + ₹9.2 Cr (Sep) in India International Bullion Holding IFSC Ltd, totaling ₹19.2 Cr. Minor capital deployment; indicates sustained focus on bullion derivatives and IFSC trading hubs.
5 · Trading window closed (Sep 25 – post-result)
Standard blackout period for designated persons and relatives from Oct 1 onwards, consistent with Nov 3 board meeting. No insider activity flagged; bulk deals in Jun–May showed UTI and others accumulating on strength.
FII & DII ownership: inflows on strength
Latest shareholding (Q1 FY27): FII 29.84% (vs 26.08% in Q4), DII 50.81% (vs 54.36% in Q4). QoQ FII inflow +3.76 percentage points, a sign of appetite for the leverage story. Bulk deals in Jun showed UTI MF buying 14.66 Cr shares at ₹2,899—a bet on momentum. No promoter stake reported in any recent quarter (consistent with IPO exit). Ownership concentration in DIIs and rising FII participation suggests institutional confidence, though valuation (P/E ~16–17× FY27 consensus earnings) leaves limited margin for disappointment.
Price & momentum: neutral, below moving averages
Price: ₹3,186.8 (Oct 27). 52-week range: ₹1,762–₹3,480; currently -8.43% from ATH, +80.86% off the lows. RSI 49 (neutral zone, no overbought signal). Volume trend normal. Notably, the stock trades below SMA20 (₹3,222.95) and SMA50 (₹3,233.43), though above SMA200 (₹2,830.52), suggesting recent consolidation after the Aug–Sep run-up. Q2 results will likely determine the next directional push.
What to watch on result day (Nov 3)
1 · Transaction revenue breakdown: bullion vs. energy vs. agricultural
Segment color on which derivatives legs are driving growth. Energy (crude, natural gas) and bullion (gold, silver) were Q1 stars; watch for any slowdown in either. Agricultural derivatives also expanding—management guidance on seasonal contribution matters.
2 · Options volumes and mix
Q1 saw options rise 4.3×. If Sep–Oct figures show this as a structural shift (options reaching 20–25% of derivative volumes), upside to consensus estimates is real. Flat or declining options would suggest the Aug spike was volatility-driven.
3 · Margin trajectory & GST provision
EBITDA margin—will it hold near 70% or compress to 60%? Any GST contingency accrual in P&L? Even a ₹50–100 Cr provision would materially lower reported profit and reset Street expectations for FY27.
4 · FY27 guidance, if offered
Management may clarify profit/revenue range for the full year. Any guidance below Street consensus (₹1,800–1,900 Cr) would trigger de-rating.
5 · Mineral Exchange launch timeline
Any update on when MCX Mineral Exchange will go live and initial product roadmap. Early revenue contribution unlikely in FY27, but execution risk on new regulatory approvals matters for FY28 narrative.
MCX enters Q2 results riding a wave of leverage—Q1 showed that a surge in commodity derivatives trading can deliver 100%+ earnings growth, capturing a margin windfall as fixed costs are spread over higher transaction volumes. The Street has priced in continued strength: analyst price targets cluster at ₹3,200–3,400, and consensus EPS for FY27 of ₹191 implies a full-year profit ~₹1,800–1,900 Cr. But momentum has stalled slightly; the stock trades below recent moving averages, and the GST show-cause notice has injected near-term earnings risk.
On Nov 3, focus on three things: (1) whether Q2 revenue holds above ₹580 Cr and profit approaches ₹350 Cr, validating the Q1 run-rate; (2) whether options volumes sustained their explosive growth, signaling a new structural tail-wind; (3) what accounting provision, if any, MCX takes for the GST liability. A strong print with muted GST impact could reignite the run toward analyst targets. A weak or cautious print would reset FY27 consensus and invite de-rating toward the lower end of the ₹3,200 target range.